Correlation of Serum Retinol and Atherogenic Indices in Type 2 Diabetes Mellitus: A Case–Control Study

Abstract

Dyslipidemia is an important risk factor for atherosclerosis and coronary heart disease, leading to mortality and morbidity in subjects with T2DM. This risk is higher in subjects with diabetes who are on retinoid therapy for some other indication, where hypercholesterolemia, hypertriglyceridemia, and low serum high-density lipoprotein cholesterol (HDL-C), and sudden cardiovascular deaths have been reported. Our study aimed to find the correlation of serum retinol and atherogenic index (AI) in subjects with T2DM and compare them with healthy controls. We found there was a significant difference in systolic and diastolic blood pressure, body mass index, waist circumference, waist hip ratio, total cholesterol (TC), Triglycerides (TG), non-high density lipoprotein cholesterol (non-HDL-C), the atherogenic ratio of cholesterol (ARC), atherogenic index of plasma (AIP) and AI between the two groups. There was a significant positive correlation of serum retinol with TC, TG, LDL-C, Non-HDL-C, ARC, AIP, and AI. In our study we found an association of serum retinol with atherogenic index and dyslipidemia in subjects with T2DM. Serum retinol can be a novel predictor of cardiovascular risk in subjects with T2DM.

This is a preview of subscription content, access via your institution.

Data Availability

Yes.

References

  1. 1.

    Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001;81(3):1269–304.

    CAS  Article  Google Scholar 

  2. 2.

    Harrison EH. Mechanisms involved in the intestinal absorption of dietary vitamin A and provitamin A carotenoids. Biochem Biophys Acta. 2012;1821(1):70–7.

    CAS  PubMed  Google Scholar 

  3. 3.

    Basu TK, Basualdo C. Vitamin A homeostasis and diabetes mellitus. Nutrition. 1997;13(9):804–6.

    CAS  Article  Google Scholar 

  4. 4.

    Larson LM, Guo J, Williams AM, Young MF, Ismaily S, Addo OY, et al. Approaches to assess vitamin a status in settings of inflammation: biomarkers reflecting inflammation and nutritional determinants of anemia (BRINDA) project. Nutrients. 2018;10(8):1100.

    Article  Google Scholar 

  5. 5.

    Ghyselinck NB, Båvik C, Sapin V, Mark M, Bonnier D, Hindelang C, et al. Cellular retinol-binding protein I is essential for vitamin A homeostasis. EMBO J. 1999;18(18):4903–14.

    CAS  Article  Google Scholar 

  6. 6.

    Rigtrup KM, Ong DE. A retinyl ester hydrolase activity intrinsic to the brush border membrane of rat small intestine. Biochemistry. 1992;31(11):2920–6.

    CAS  Article  Google Scholar 

  7. 7.

    Redlich CA, Chung JS, Cullen MR, Blaner WS, Van Bennekum AM, Berglund L. Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the carotene and retinol efficacy trial (CARET). Atherosclerosis. 1999;143(2):427–34.

    CAS  Article  Google Scholar 

  8. 8.

    Zech LA, Gross EG, Peck GL, Brewer HB. Changes in plasma cholesterol and triglyceride levels after treatment with oral isotretinoin: a prospective study. Arch Dermatol. 1983;119(12):987–93.

    CAS  Article  Google Scholar 

  9. 9.

    Mantel-Teeuwisse AK, Kloosterman JME, Zee MAH, Klungel OH, Porsius AJ, De Boer A. Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf. 2001;24(6):443–56.

    CAS  Article  Google Scholar 

  10. 10.

    Cartmel B, Dziura J, Cullen MR, Vegso S, Omenn GS, Goodman GE, et al. Changes in cholesterol and triglyceride concentrations in the Vanguard population of the carotene and retinol efficacy trial (CARET). Eur J Clin Nutr. 2005;59(10):1173–80.

    CAS  Article  Google Scholar 

  11. 11.

    Cleeman JI, Lenfant C. The National Cholesterol Education Program. Progress and prospects. J Am Med Assoc. 1998;280(24):2099–104.

    CAS  Article  Google Scholar 

  12. 12.

    Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Int Med. 2003;163(4):427–36.

    Article  Google Scholar 

  13. 13.

    Vergès B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886–99.

    Article  Google Scholar 

  14. 14.

    Holman R. UK prospective diabetes study (completed). 1998;20(11):1683–7. Available from: https://www.dtu.ox.ac.uk/UKPDS. Accessed 18th Apr 2020.

  15. 15.

    Cowie CC, Howard BV, Harris MI. Serum lipoproteins in African Americans and whites with non-insulin- dependent diabetes in the US population. Circulation. 1994;90(3):1185–93.

    CAS  Article  Google Scholar 

  16. 16.

    Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013;13(10):709–21.

    CAS  Article  Google Scholar 

  17. 17.

    Remmerie A, Scott CL. Macrophages and lipid metabolism. Cell Immunol. 2018;330(January):27–42.

    CAS  Article  Google Scholar 

  18. 18.

    Turner RC, Millns H, Holman RR. Coronary heart disease and risk factors in NIDDM—experience from the United Kingdom prospective diabetes study. Diabetologia. 1997;40(Suppl. 2):121–2.

    Article  Google Scholar 

  19. 19.

    American Diabetes Association. Cardiovascular disease and risk management: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Suppl 1):s103–23.

    Article  Google Scholar 

  20. 20.

    Wang YS, Ye J, Yang X, Zhang GP, Cao YH, Zhang R, et al. Association of retinol binding protein-4, cystatin C, homocysteine and high-sensitivity C-reactive protein levels in patients with newly diagnosed type 2 diabetes mellitus. Arch Med Sci. 2019;15(5):1203–16.

    CAS  Article  Google Scholar 

  21. 21.

    Burtis CA, Ashwood ER, Bruns DE. Teitz textbook of clinical chemistry and molecular diagnostics. 5th ed. St.Louis: Elsevier Inc; 2012. p. 1587–9.

    Google Scholar 

  22. 22.

    Barua AB. Improved normal-phase and reversed-phase gradient high-performance liquid chromatography procedures for the analysis of retinoids and carotenoids in human serum, plant and animal tissues. J Chromatogr A. 2001;936(1–2):71–82.

    CAS  Article  Google Scholar 

  23. 23.

    Craft NE, Furr HC. Methods for assessment of vitamin A (retinoids) and carotenoids [Internet]. Laboratory Assessment of Vitamin Status. Elsevier Inc.; 2018. p. 21–47. Available from: https://doi.org/10.1016/B978-0-12-813050-6.00002-4. Accessed 13th Sep 2019.

  24. 24.

    Jordan P, Brubacher D, Moser U, Stahelin HB, Gey KF. Vitamin E and vitamin A concentrations in plasma adjusted for cholesterol and triglycerides by multiple regression. Clin Chem. 1995;41(6):924–7.

    CAS  Article  Google Scholar 

  25. 25.

    Namaste SM, Aaron GJ, Varadhan R, Peerson JM, Suchdev PS. Methodologic approach for the biomarkers reflecting inflammation and nutritional determinants of anemia (BRINDA) project. Am J Clin Nutr. 2017;106:333S–47S.

    PubMed  PubMed Central  Google Scholar 

  26. 26.

    Gouado I, Ejoh RA, Kenne M, Ndifor F, Mbiapo FT. Serum concentration of vitamins A and E and lipid in a rural population of North Cameroon. Ann Nutr Metab. 2005;49(1):26–32.

    CAS  Article  Google Scholar 

  27. 27.

    Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 2018;17(1):1–7.

    CAS  Article  Google Scholar 

  28. 28.

    Staels B. Regulation of lipid and lipoprotein metabolism by retinoids. J Am Acad Dermatol. 2001;45(5):158–67.

    Article  Google Scholar 

  29. 29.

    Vahlquist A. Retinoid-induced hyperlipidemia and the risk of atherosclerosis. 29(1):26–30. [Internet]. Retinoids and carotenoids in dermatology. Downloaded from informahealthcare.com by Nyu Medical Center. Accessed 15th Apr 2020.

  30. 30.

    Sparks JD, Dong HH. FoxO1 and hepatic lipid metabolism. Curr Opin Lipidol. 2009;20(3):217–26.

    CAS  Article  Google Scholar 

  31. 31.

    Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem. 2000;275(21):15985–91.

    CAS  Article  Google Scholar 

  32. 32.

    Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ, et al. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice. J Biol Chem. 2001;276(51):47944–9.

    CAS  Article  Google Scholar 

  33. 33.

    Berry DC, Jin H, Majumdar A, Noy N. Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses. Proc Natl Acad Sci U S A. 2011;108(11):4340–5.

    CAS  Article  Google Scholar 

  34. 34.

    Klör HU, Weizel A, Augustin M, Diepgen TL, Elsner P, Homey B, et al. The impact of oral vitamin A derivatives on lipid metabolism—what recommendations can be derived for dealing with this issue in the daily dermatological practice? J Dtsch Dermatol Ges. 2011;9(8):600–6.

    PubMed  Google Scholar 

Download references

Funding

None.

Author information

Affiliations

Authors

Contributions

Conceptualization, Methodology: DB, SS, CCXJ; Data collection: CCXJ; Investigation and data analysis: CCXJ, SN; Writing, review and editing: SS, CCXJ, DB; Resources: BKP, SS, DB, CCXJ; Supervision: SS.

Corresponding author

Correspondence to Debapriya Bandyopadhyay.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

This study was approved by the Institutional Ethics committee (IEC) (Registration Number: ECR/534/Inst/OD/2014/RR-17), AIIMS, Bhubaneswar, India. (vide approval number: IEC/AIIMS BBSR/PG Thesis/2018-19/10 dated - 13 July 2018).

Informed Consent

Written informed consent was obtained from the participants.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jyothi, C.C.X., Bandyopadhyay, D., Sahu, S. et al. Correlation of Serum Retinol and Atherogenic Indices in Type 2 Diabetes Mellitus: A Case–Control Study. Ind J Clin Biochem (2021). https://doi.org/10.1007/s12291-020-00951-0

Download citation

Keywords

  • Vitamin A
  • Retinoid therapy
  • Atherosclerosis
  • Cardiovascular
  • Dyslipidaemia